Drug updated on 11/15/2023
|Nebulizer (oral inhalation; 175 mcg/3mL)
| Ongoing and
- To maintain treatment of chronic obstructive pulmonary disease.
Product Monograph / Prescribing Information
|Yupelri (revefenacin) Prescribing Information.
|Mylan Specialty L.P., Morgantown, WV
Systematic Reviews / Meta-Analyses
|Safety evaluation of revefenacin at the approved dose in patients with chronic obstructive pulmonary disease: a meta-analysis.
|Heart & Lung: The Journal of Acute and Critical Care
|The efficacy and safety of revefenacin for the treatment of chronic obstructive pulmonary disease: a systematic review.
|Frontiers in Pharmacology
|Efficacy of revefenacin in treatment of moderate-to-very-severe chronic obstructive pulmonary disease: a systematic review and meta-analysis.
|Journal of Health Policy and Economics